PH30180A - Leustroducsin h its preparation and its therapeutic use - Google Patents
Leustroducsin h its preparation and its therapeutic useInfo
- Publication number
- PH30180A PH30180A PH48120A PH48120A PH30180A PH 30180 A PH30180 A PH 30180A PH 48120 A PH48120 A PH 48120A PH 48120 A PH48120 A PH 48120A PH 30180 A PH30180 A PH 30180A
- Authority
- PH
- Philippines
- Prior art keywords
- leustroducsin
- preparation
- therapeutic use
- compound
- leustroducsins
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 206010043554 thrombocytopenia Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9805893 | 1993-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30180A true PH30180A (en) | 1997-01-21 |
Family
ID=14209715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH48120A PH30180A (en) | 1993-04-23 | 1994-04-20 | Leustroducsin h its preparation and its therapeutic use |
Country Status (19)
Country | Link |
---|---|
US (1) | US5409912A (de) |
EP (1) | EP0622372B1 (de) |
JP (1) | JPH072886A (de) |
CN (1) | CN1050845C (de) |
AT (1) | ATE166058T1 (de) |
AU (1) | AU665488B2 (de) |
CA (1) | CA2121735A1 (de) |
CZ (1) | CZ286364B6 (de) |
DE (1) | DE69410159T2 (de) |
DK (1) | DK0622372T3 (de) |
ES (1) | ES2116528T3 (de) |
FI (1) | FI941850A (de) |
HK (1) | HK1007857A1 (de) |
HU (1) | HU220223B (de) |
IL (1) | IL109227A (de) |
NO (1) | NO303640B1 (de) |
NZ (1) | NZ260364A (de) |
PH (1) | PH30180A (de) |
RU (1) | RU2098422C1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997014704A1 (fr) * | 1995-10-17 | 1997-04-24 | Suntory Limited | Medicament contre la thrombopenie |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2865302B2 (ja) * | 1988-02-13 | 1999-03-08 | サントリー株式会社 | 2―ピラノン誘導体及びその製造法並びにそれを含む抗菌剤 |
AU649116B2 (en) * | 1991-03-27 | 1994-05-12 | Sankyo Company Limited | New compounds, named the "Leustroducins", their preparation and their therapeutic uses |
JPH05213758A (ja) * | 1992-02-06 | 1993-08-24 | Sankyo Co Ltd | 血小板増多剤 |
-
1994
- 1994-03-31 AT AT94302367T patent/ATE166058T1/de not_active IP Right Cessation
- 1994-03-31 EP EP94302367A patent/EP0622372B1/de not_active Expired - Lifetime
- 1994-03-31 ES ES94302367T patent/ES2116528T3/es not_active Expired - Lifetime
- 1994-03-31 DE DE69410159T patent/DE69410159T2/de not_active Expired - Fee Related
- 1994-03-31 DK DK94302367T patent/DK0622372T3/da active
- 1994-04-05 IL IL10922794A patent/IL109227A/en not_active IP Right Cessation
- 1994-04-08 US US08/224,424 patent/US5409912A/en not_active Expired - Fee Related
- 1994-04-08 AU AU59323/94A patent/AU665488B2/en not_active Ceased
- 1994-04-18 JP JP6078290A patent/JPH072886A/ja active Pending
- 1994-04-20 CA CA002121735A patent/CA2121735A1/en not_active Abandoned
- 1994-04-20 PH PH48120A patent/PH30180A/en unknown
- 1994-04-21 CZ CZ1994964A patent/CZ286364B6/cs not_active IP Right Cessation
- 1994-04-21 FI FI941850A patent/FI941850A/fi unknown
- 1994-04-21 NZ NZ260364A patent/NZ260364A/en unknown
- 1994-04-22 NO NO941478A patent/NO303640B1/no not_active IP Right Cessation
- 1994-04-22 RU RU9494013445A patent/RU2098422C1/ru active
- 1994-04-22 HU HU9401159A patent/HU220223B/hu not_active IP Right Cessation
- 1994-04-23 CN CN94104621A patent/CN1050845C/zh not_active Expired - Fee Related
-
1998
- 1998-06-26 HK HK98106941A patent/HK1007857A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1105027A (zh) | 1995-07-12 |
CZ286364B6 (cs) | 2000-03-15 |
IL109227A0 (en) | 1994-07-31 |
EP0622372A1 (de) | 1994-11-02 |
EP0622372B1 (de) | 1998-05-13 |
US5409912A (en) | 1995-04-25 |
NZ260364A (en) | 1995-07-26 |
CN1050845C (zh) | 2000-03-29 |
AU5932394A (en) | 1994-10-27 |
NO303640B1 (no) | 1998-08-10 |
NO941478L (no) | 1994-10-24 |
DE69410159D1 (de) | 1998-06-18 |
CZ96494A3 (en) | 1994-11-16 |
NO941478D0 (no) | 1994-04-22 |
ATE166058T1 (de) | 1998-05-15 |
DK0622372T3 (da) | 1999-02-15 |
AU665488B2 (en) | 1996-01-04 |
HU9401159D0 (en) | 1994-07-28 |
FI941850A (fi) | 1994-10-24 |
FI941850A0 (fi) | 1994-04-21 |
HK1007857A1 (en) | 1999-04-23 |
RU2098422C1 (ru) | 1997-12-10 |
HUT68015A (en) | 1995-05-29 |
DE69410159T2 (de) | 1999-01-28 |
HU220223B (hu) | 2001-11-28 |
IL109227A (en) | 1998-01-04 |
JPH072886A (ja) | 1995-01-06 |
CA2121735A1 (en) | 1994-10-24 |
ES2116528T3 (es) | 1998-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0156747B1 (en) | Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b | |
HUT59109A (en) | Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same | |
ZA95631B (en) | Prolineamide derivatives | |
IN172553B (de) | ||
AU1302388A (en) | Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides | |
AU2101592A (en) | Piperidine derivatives | |
ZA941464B (en) | Use of pregnane derivative | |
HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
GR3007079T3 (de) | ||
TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
NZ332687A (en) | use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents | |
HK1007857A1 (en) | New compound leustroducsin H its preparation and its therapeutic use | |
DK0855398T3 (da) | Sesquiterpenderivater med antiviral aktivitet | |
AU2101792A (en) | Methanoanthracene D2 dopamine antagonists | |
AU2532692A (en) | Method for treating hypertension | |
IL114866A0 (en) | Process for the preparation of the (-)-n-methyl-n-Ú4-(4-phenyl-4-acetylaminopiperidin-1-yl-2-(3,4-dichlorophenyl) butyl¾ benzamide | |
TW275629B (de) |